line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,LYPSAGEMS.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.001218,LYPSAGEMS.NS
Normalized EBITDA,2025-03-31 00:00:00,-149786000.0,LYPSAGEMS.NS
Total Unusual Items,2025-03-31 00:00:00,,LYPSAGEMS.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,,LYPSAGEMS.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,-151747000.0,LYPSAGEMS.NS
Reconciled Depreciation,2025-03-31 00:00:00,2146000.0,LYPSAGEMS.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,162711000.0,LYPSAGEMS.NS
EBITDA,2025-03-31 00:00:00,-149786000.0,LYPSAGEMS.NS
EBIT,2025-03-31 00:00:00,-151932000.0,LYPSAGEMS.NS
Net Interest Income,2025-03-31 00:00:00,0.0,LYPSAGEMS.NS
Interest Expense,2025-03-31 00:00:00,0.0,LYPSAGEMS.NS
Interest Income,2025-03-31 00:00:00,,LYPSAGEMS.NS
Normalized Income,2025-03-31 00:00:00,-151747000.0,LYPSAGEMS.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,-151747000.0,LYPSAGEMS.NS
Total Expenses,2025-03-31 00:00:00,318808000.0,LYPSAGEMS.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,LYPSAGEMS.NS
Diluted Average Shares,2025-03-31 00:00:00,29465437.0,LYPSAGEMS.NS
Basic Average Shares,2025-03-31 00:00:00,29465437.0,LYPSAGEMS.NS
Diluted EPS,2025-03-31 00:00:00,-5.15,LYPSAGEMS.NS
Basic EPS,2025-03-31 00:00:00,-5.15,LYPSAGEMS.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,-151747000.0,LYPSAGEMS.NS
Net Income Common Stockholders,2025-03-31 00:00:00,-151747000.0,LYPSAGEMS.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,LYPSAGEMS.NS
Net Income,2025-03-31 00:00:00,-151747000.0,LYPSAGEMS.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,-151747000.0,LYPSAGEMS.NS
Net Income Discontinuous Operations,2025-03-31 00:00:00,,LYPSAGEMS.NS
Net Income Continuous Operations,2025-03-31 00:00:00,-151747000.0,LYPSAGEMS.NS
Tax Provision,2025-03-31 00:00:00,-185000.0,LYPSAGEMS.NS
Pretax Income,2025-03-31 00:00:00,-151932000.0,LYPSAGEMS.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,,LYPSAGEMS.NS
Special Income Charges,2025-03-31 00:00:00,,LYPSAGEMS.NS
Other Special Charges,2025-03-31 00:00:00,,LYPSAGEMS.NS
Write Off,2025-03-31 00:00:00,,LYPSAGEMS.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,0.0,LYPSAGEMS.NS
Interest Expense Non Operating,2025-03-31 00:00:00,0.0,LYPSAGEMS.NS
Interest Income Non Operating,2025-03-31 00:00:00,,LYPSAGEMS.NS
Operating Income,2025-03-31 00:00:00,-151932000.0,LYPSAGEMS.NS
Operating Expense,2025-03-31 00:00:00,156097000.0,LYPSAGEMS.NS
Other Operating Expenses,2025-03-31 00:00:00,153783000.0,LYPSAGEMS.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,2146000.0,LYPSAGEMS.NS
Depreciation Income Statement,2025-03-31 00:00:00,2146000.0,LYPSAGEMS.NS
Selling General And Administration,2025-03-31 00:00:00,,LYPSAGEMS.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,LYPSAGEMS.NS
General And Administrative Expense,2025-03-31 00:00:00,,LYPSAGEMS.NS
Rent And Landing Fees,2025-03-31 00:00:00,,LYPSAGEMS.NS
Gross Profit,2025-03-31 00:00:00,4165000.0,LYPSAGEMS.NS
Cost Of Revenue,2025-03-31 00:00:00,162711000.0,LYPSAGEMS.NS
Total Revenue,2025-03-31 00:00:00,166876000.0,LYPSAGEMS.NS
Operating Revenue,2025-03-31 00:00:00,166876000.0,LYPSAGEMS.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,LYPSAGEMS.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.3,LYPSAGEMS.NS
Normalized EBITDA,2024-03-31 00:00:00,-324343000.0,LYPSAGEMS.NS
Total Unusual Items,2024-03-31 00:00:00,0.0,LYPSAGEMS.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,0.0,LYPSAGEMS.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,-327117000.0,LYPSAGEMS.NS
Reconciled Depreciation,2024-03-31 00:00:00,2358000.0,LYPSAGEMS.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,90988000.0,LYPSAGEMS.NS
EBITDA,2024-03-31 00:00:00,-324343000.0,LYPSAGEMS.NS
EBIT,2024-03-31 00:00:00,-326701000.0,LYPSAGEMS.NS
Net Interest Income,2024-03-31 00:00:00,-1000.0,LYPSAGEMS.NS
Interest Expense,2024-03-31 00:00:00,1000.0,LYPSAGEMS.NS
Interest Income,2024-03-31 00:00:00,0.0,LYPSAGEMS.NS
Normalized Income,2024-03-31 00:00:00,-327117000.0,LYPSAGEMS.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,-327117000.0,LYPSAGEMS.NS
Total Expenses,2024-03-31 00:00:00,421555000.0,LYPSAGEMS.NS
Rent Expense Supplemental,2024-03-31 00:00:00,,LYPSAGEMS.NS
Diluted Average Shares,2024-03-31 00:00:00,29496573.0,LYPSAGEMS.NS
Basic Average Shares,2024-03-31 00:00:00,29496573.0,LYPSAGEMS.NS
Diluted EPS,2024-03-31 00:00:00,-11.09,LYPSAGEMS.NS
Basic EPS,2024-03-31 00:00:00,-11.09,LYPSAGEMS.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,-327117000.0,LYPSAGEMS.NS
Net Income Common Stockholders,2024-03-31 00:00:00,-327117000.0,LYPSAGEMS.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,LYPSAGEMS.NS
Net Income,2024-03-31 00:00:00,-327117000.0,LYPSAGEMS.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,-327117000.0,LYPSAGEMS.NS
Net Income Discontinuous Operations,2024-03-31 00:00:00,0.0,LYPSAGEMS.NS
Net Income Continuous Operations,2024-03-31 00:00:00,-327117000.0,LYPSAGEMS.NS
Tax Provision,2024-03-31 00:00:00,415000.0,LYPSAGEMS.NS
Pretax Income,2024-03-31 00:00:00,-326702000.0,LYPSAGEMS.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,,LYPSAGEMS.NS
Special Income Charges,2024-03-31 00:00:00,,LYPSAGEMS.NS
Other Special Charges,2024-03-31 00:00:00,,LYPSAGEMS.NS
Write Off,2024-03-31 00:00:00,,LYPSAGEMS.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-1000.0,LYPSAGEMS.NS
Interest Expense Non Operating,2024-03-31 00:00:00,1000.0,LYPSAGEMS.NS
Interest Income Non Operating,2024-03-31 00:00:00,0.0,LYPSAGEMS.NS
Operating Income,2024-03-31 00:00:00,-326701000.0,LYPSAGEMS.NS
Operating Expense,2024-03-31 00:00:00,330567000.0,LYPSAGEMS.NS
Other Operating Expenses,2024-03-31 00:00:00,328041000.0,LYPSAGEMS.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,2358000.0,LYPSAGEMS.NS
Depreciation Income Statement,2024-03-31 00:00:00,2358000.0,LYPSAGEMS.NS
Selling General And Administration,2024-03-31 00:00:00,,LYPSAGEMS.NS
Selling And Marketing Expense,2024-03-31 00:00:00,,LYPSAGEMS.NS
General And Administrative Expense,2024-03-31 00:00:00,,LYPSAGEMS.NS
Rent And Landing Fees,2024-03-31 00:00:00,,LYPSAGEMS.NS
Gross Profit,2024-03-31 00:00:00,3866000.0,LYPSAGEMS.NS
Cost Of Revenue,2024-03-31 00:00:00,90988000.0,LYPSAGEMS.NS
Total Revenue,2024-03-31 00:00:00,94854000.0,LYPSAGEMS.NS
Operating Revenue,2024-03-31 00:00:00,94854000.0,LYPSAGEMS.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.3,LYPSAGEMS.NS
Normalized EBITDA,2023-03-31 00:00:00,-438217000.0,LYPSAGEMS.NS
Total Unusual Items,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,-440972000.0,LYPSAGEMS.NS
Reconciled Depreciation,2023-03-31 00:00:00,2719000.0,LYPSAGEMS.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,128535000.0,LYPSAGEMS.NS
EBITDA,2023-03-31 00:00:00,-438217000.0,LYPSAGEMS.NS
EBIT,2023-03-31 00:00:00,-440936000.0,LYPSAGEMS.NS
Net Interest Income,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
Interest Expense,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
Interest Income,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
Normalized Income,2023-03-31 00:00:00,-440972000.0,LYPSAGEMS.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,-440972000.0,LYPSAGEMS.NS
Total Expenses,2023-03-31 00:00:00,572871000.0,LYPSAGEMS.NS
Rent Expense Supplemental,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
Diluted Average Shares,2023-03-31 00:00:00,29484000.0,LYPSAGEMS.NS
Basic Average Shares,2023-03-31 00:00:00,29484000.0,LYPSAGEMS.NS
Diluted EPS,2023-03-31 00:00:00,-14.96,LYPSAGEMS.NS
Basic EPS,2023-03-31 00:00:00,-14.96,LYPSAGEMS.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,-440972000.0,LYPSAGEMS.NS
Net Income Common Stockholders,2023-03-31 00:00:00,-440972000.0,LYPSAGEMS.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
Net Income,2023-03-31 00:00:00,-440972000.0,LYPSAGEMS.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,-440972000.0,LYPSAGEMS.NS
Net Income Discontinuous Operations,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
Net Income Continuous Operations,2023-03-31 00:00:00,-440972000.0,LYPSAGEMS.NS
Tax Provision,2023-03-31 00:00:00,36000.0,LYPSAGEMS.NS
Pretax Income,2023-03-31 00:00:00,-440936000.0,LYPSAGEMS.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,,LYPSAGEMS.NS
Special Income Charges,2023-03-31 00:00:00,-439452000.0,LYPSAGEMS.NS
Other Special Charges,2023-03-31 00:00:00,,LYPSAGEMS.NS
Write Off,2023-03-31 00:00:00,439452000.0,LYPSAGEMS.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
Interest Expense Non Operating,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
Interest Income Non Operating,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
Operating Income,2023-03-31 00:00:00,-440936000.0,LYPSAGEMS.NS
Operating Expense,2023-03-31 00:00:00,444336000.0,LYPSAGEMS.NS
Other Operating Expenses,2023-03-31 00:00:00,441461000.0,LYPSAGEMS.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,2719000.0,LYPSAGEMS.NS
Depreciation Income Statement,2023-03-31 00:00:00,2719000.0,LYPSAGEMS.NS
Selling General And Administration,2023-03-31 00:00:00,1930000.0,LYPSAGEMS.NS
Selling And Marketing Expense,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
General And Administrative Expense,2023-03-31 00:00:00,1930000.0,LYPSAGEMS.NS
Rent And Landing Fees,2023-03-31 00:00:00,0.0,LYPSAGEMS.NS
Gross Profit,2023-03-31 00:00:00,3400000.0,LYPSAGEMS.NS
Cost Of Revenue,2023-03-31 00:00:00,128535000.0,LYPSAGEMS.NS
Total Revenue,2023-03-31 00:00:00,131935000.0,LYPSAGEMS.NS
Operating Revenue,2023-03-31 00:00:00,131935000.0,LYPSAGEMS.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,444907.97546,LYPSAGEMS.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.245399,LYPSAGEMS.NS
Normalized EBITDA,2022-03-31 00:00:00,-224000.0,LYPSAGEMS.NS
Total Unusual Items,2022-03-31 00:00:00,1813000.0,LYPSAGEMS.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,1813000.0,LYPSAGEMS.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,-861000.0,LYPSAGEMS.NS
Reconciled Depreciation,2022-03-31 00:00:00,2730000.0,LYPSAGEMS.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,136913000.0,LYPSAGEMS.NS
EBITDA,2022-03-31 00:00:00,1589000.0,LYPSAGEMS.NS
EBIT,2022-03-31 00:00:00,-1141000.0,LYPSAGEMS.NS
Net Interest Income,2022-03-31 00:00:00,0.0,LYPSAGEMS.NS
Interest Expense,2022-03-31 00:00:00,0.0,LYPSAGEMS.NS
Interest Income,2022-03-31 00:00:00,0.0,LYPSAGEMS.NS
Normalized Income,2022-03-31 00:00:00,-2229092.02454,LYPSAGEMS.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,-861000.0,LYPSAGEMS.NS
Total Expenses,2022-03-31 00:00:00,143194000.0,LYPSAGEMS.NS
Rent Expense Supplemental,2022-03-31 00:00:00,0.0,LYPSAGEMS.NS
Diluted Average Shares,2022-03-31 00:00:00,29484000.0,LYPSAGEMS.NS
Basic Average Shares,2022-03-31 00:00:00,29484000.0,LYPSAGEMS.NS
Diluted EPS,2022-03-31 00:00:00,-0.03,LYPSAGEMS.NS
Basic EPS,2022-03-31 00:00:00,-0.03,LYPSAGEMS.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,-861000.0,LYPSAGEMS.NS
Net Income Common Stockholders,2022-03-31 00:00:00,-861000.0,LYPSAGEMS.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,LYPSAGEMS.NS
Net Income,2022-03-31 00:00:00,-861000.0,LYPSAGEMS.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,-861000.0,LYPSAGEMS.NS
Net Income Discontinuous Operations,2022-03-31 00:00:00,0.0,LYPSAGEMS.NS
Net Income Continuous Operations,2022-03-31 00:00:00,-861000.0,LYPSAGEMS.NS
Tax Provision,2022-03-31 00:00:00,-280000.0,LYPSAGEMS.NS
Pretax Income,2022-03-31 00:00:00,-1141000.0,LYPSAGEMS.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,2000.0,LYPSAGEMS.NS
Special Income Charges,2022-03-31 00:00:00,1813000.0,LYPSAGEMS.NS
Other Special Charges,2022-03-31 00:00:00,101000.0,LYPSAGEMS.NS
Write Off,2022-03-31 00:00:00,-1914000.0,LYPSAGEMS.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,0.0,LYPSAGEMS.NS
Interest Expense Non Operating,2022-03-31 00:00:00,0.0,LYPSAGEMS.NS
Interest Income Non Operating,2022-03-31 00:00:00,0.0,LYPSAGEMS.NS
Operating Income,2022-03-31 00:00:00,-2956000.0,LYPSAGEMS.NS
Operating Expense,2022-03-31 00:00:00,6281000.0,LYPSAGEMS.NS
Other Operating Expenses,2022-03-31 00:00:00,266000.0,LYPSAGEMS.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,2730000.0,LYPSAGEMS.NS
Depreciation Income Statement,2022-03-31 00:00:00,2730000.0,LYPSAGEMS.NS
Selling General And Administration,2022-03-31 00:00:00,1958000.0,LYPSAGEMS.NS
Selling And Marketing Expense,2022-03-31 00:00:00,0.0,LYPSAGEMS.NS
General And Administrative Expense,2022-03-31 00:00:00,1958000.0,LYPSAGEMS.NS
Rent And Landing Fees,2022-03-31 00:00:00,0.0,LYPSAGEMS.NS
Gross Profit,2022-03-31 00:00:00,3325000.0,LYPSAGEMS.NS
Cost Of Revenue,2022-03-31 00:00:00,136913000.0,LYPSAGEMS.NS
Total Revenue,2022-03-31 00:00:00,140238000.0,LYPSAGEMS.NS
Operating Revenue,2022-03-31 00:00:00,140238000.0,LYPSAGEMS.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,LYPSAGEMS.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,LYPSAGEMS.NS
Normalized EBITDA,2021-03-31 00:00:00,,LYPSAGEMS.NS
Total Unusual Items,2021-03-31 00:00:00,885000.0,LYPSAGEMS.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,885000.0,LYPSAGEMS.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,LYPSAGEMS.NS
Reconciled Depreciation,2021-03-31 00:00:00,,LYPSAGEMS.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,LYPSAGEMS.NS
EBITDA,2021-03-31 00:00:00,,LYPSAGEMS.NS
EBIT,2021-03-31 00:00:00,,LYPSAGEMS.NS
Net Interest Income,2021-03-31 00:00:00,,LYPSAGEMS.NS
Interest Expense,2021-03-31 00:00:00,,LYPSAGEMS.NS
Interest Income,2021-03-31 00:00:00,0.0,LYPSAGEMS.NS
Normalized Income,2021-03-31 00:00:00,,LYPSAGEMS.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,LYPSAGEMS.NS
Total Expenses,2021-03-31 00:00:00,,LYPSAGEMS.NS
Rent Expense Supplemental,2021-03-31 00:00:00,0.0,LYPSAGEMS.NS
Diluted Average Shares,2021-03-31 00:00:00,,LYPSAGEMS.NS
Basic Average Shares,2021-03-31 00:00:00,,LYPSAGEMS.NS
Diluted EPS,2021-03-31 00:00:00,,LYPSAGEMS.NS
Basic EPS,2021-03-31 00:00:00,,LYPSAGEMS.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,LYPSAGEMS.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,LYPSAGEMS.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,LYPSAGEMS.NS
Net Income,2021-03-31 00:00:00,,LYPSAGEMS.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,LYPSAGEMS.NS
Net Income Discontinuous Operations,2021-03-31 00:00:00,,LYPSAGEMS.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,LYPSAGEMS.NS
Tax Provision,2021-03-31 00:00:00,,LYPSAGEMS.NS
Pretax Income,2021-03-31 00:00:00,,LYPSAGEMS.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,LYPSAGEMS.NS
Special Income Charges,2021-03-31 00:00:00,885000.0,LYPSAGEMS.NS
Other Special Charges,2021-03-31 00:00:00,-885000.0,LYPSAGEMS.NS
Write Off,2021-03-31 00:00:00,0.0,LYPSAGEMS.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,LYPSAGEMS.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,LYPSAGEMS.NS
Interest Income Non Operating,2021-03-31 00:00:00,0.0,LYPSAGEMS.NS
Operating Income,2021-03-31 00:00:00,,LYPSAGEMS.NS
Operating Expense,2021-03-31 00:00:00,,LYPSAGEMS.NS
Other Operating Expenses,2021-03-31 00:00:00,,LYPSAGEMS.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,LYPSAGEMS.NS
Depreciation Income Statement,2021-03-31 00:00:00,,LYPSAGEMS.NS
Selling General And Administration,2021-03-31 00:00:00,1036000.0,LYPSAGEMS.NS
Selling And Marketing Expense,2021-03-31 00:00:00,0.0,LYPSAGEMS.NS
General And Administrative Expense,2021-03-31 00:00:00,1036000.0,LYPSAGEMS.NS
Rent And Landing Fees,2021-03-31 00:00:00,0.0,LYPSAGEMS.NS
Gross Profit,2021-03-31 00:00:00,,LYPSAGEMS.NS
Cost Of Revenue,2021-03-31 00:00:00,,LYPSAGEMS.NS
Total Revenue,2021-03-31 00:00:00,,LYPSAGEMS.NS
Operating Revenue,2021-03-31 00:00:00,,LYPSAGEMS.NS
